Home › Funds › COBALT CAPITAL MANAGEMENT, INC. › DMAC
COBALT CAPITAL MANAGEMENT, INC. position in DMAC
DIAMEDICA THERAPEUTICS INC · Health Care
COBALT CAPITAL MANAGEMENT, INC. reported holding 104,872 shares of DMAC (DIAMEDICA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$867K, representing 0.50% of its reported portfolio and ranking #23 among its reported holdings. COBALT CAPITAL MANAGEMENT, INC. has disclosed DMAC holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How COBALT CAPITAL MANAGEMENT, INC.'s DMAC position evolved
COBALT CAPITAL MANAGEMENT, INC. first disclosed a stake in DMAC in Q2 2026 at 90,000 shares (US$634K). The position peaked in Q3 2026 at 104,872 shares, worth US$867K. Across 2 filings, COBALT CAPITAL MANAGEMENT, INC. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 104,872 shares valued at US$867K — an increase of 14,872 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 90.00K | $633.60K | New |
| Q3 2026 | 104.87K | $867.29K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DMAC and 13F data
DMAC (DIAMEDICA THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in DMAC — the largest reported positions include COOPERMAN LEON G (US$24.3M), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (US$5.9M), MEMBERS WEALTH LLC (US$810K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DMAC
- COOPERMAN LEON G 3.45M sh · $24.29M · Q2 2026
- PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 875.00K sh · $5.92M · Q1 2026
- MEMBERS WEALTH LLC 101.38K sh · $810.04K · Q3 2026
More on COBALT CAPITAL MANAGEMENT, INC.
FAQ
How long has COBALT CAPITAL MANAGEMENT, INC. held DMAC?
COBALT CAPITAL MANAGEMENT, INC. has disclosed DMAC holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is COBALT CAPITAL MANAGEMENT, INC.'s current position in DMAC?
As of Q3 2026, COBALT CAPITAL MANAGEMENT, INC. holds 104.87K shares of DMAC (DIAMEDICA THERAPEUTICS INC), valued at $867.29K, representing 0.50% of its reported portfolio and ranking #23.
Has COBALT CAPITAL MANAGEMENT, INC. been buying or selling DMAC?
In the latest 13F filing (Q3 2026), COBALT CAPITAL MANAGEMENT, INC. increased its position in DMAC. The position peaked in Q3 2026 at 104.87K shares.
Which other funds hold DMAC?
Other major institutional holders of DMAC include COOPERMAN LEON G, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, MEMBERS WEALTH LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.